Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol.

Authors :: Harb T
Ziogos E
Schär M
Brown TT
Lai S
Gerstenblith G
Hays AG
Leucker TM
Source :: Circulation. Cardiovascular imaging [Circ Cardiovasc Imaging] 2023 Oct; Vol. 16 (10), pp. e015693. Date of Electronic Publication: 2023 Sep 29.
Publication Year :: 2023
Abstract: Competing Interests: Disclosures Dr Leucker reports a research grant from Amgen. Dr Brown has served as a consultant to Merck, ViiV Healthcare, Gilead Sciences, Janssen, and Theratechnologies. The other authors report no conflicts.

Subjects :: Humans
Cholesterol, LDL
Lipoprotein(a)
Proprotein Convertase 9
HIV Infections diagnosis
HIV Infections drug therapy
HIV Infections complications

Full Text Access

Tools